Carlsmed, Inc Common Stock

Yahoo Finance • 3 days ago

Carlsmed joins Russell 2000 Index following Q3 IPO

* Carlsmed (NASDAQ:CARL [https://seekingalpha.com/symbol/CARL]) added to the Russell 2000 Index effective after market close on September 22, 2025. * Inclusion follows Carlsmed’s IPO in July 2025, part of Q3 index rebalancing. * Sour... Full story

Yahoo Finance • 3 days ago

Carlsmed, Inc. Selected for Inclusion in Russell 2000® Index

CARLSBAD, Calif., Sept. 22, 2025 (GLOBE NEWSWIRE) -- Carlsmed, Inc. (Nasdaq: CARL) (“Carlsmed” or the “Company”), a medical technology company pioneering AI-enabled personalized spine surgery solutions, today announced that effective aft... Full story

Yahoo Finance • 13 days ago

Here’s Goldman Sachs’ Next S&P 500 Target — Plus 2 Top Stock Picks

The stock markets are at record highs, having shown a solid recovery from their sharp losses in April. Year-to-date, the S&P 500 is up 11% and the NASDAQ is up 13.5%, reflecting continued positive sentiment. Elevate Your Investing Strateg... Full story

Yahoo Finance • 16 days ago

Carlsberg (CPSE:CARL B): Exploring Valuation After Recent Quiet Share Price Drift

Carlsberg (CPSE:CARL B) has been on the radar lately as its shares have drifted lower in recent weeks, even though there has been no headline-grabbing event to drive the moves. Sometimes, it is the subtle shifts that spark the biggest ques... Full story

Yahoo Finance • 27 days ago

Carlsmed, Inc. Q2 Sales Increase

(RTTNews) - Carlsmed, Inc. (CARL) released Loss for second quarter of -$6.77 million The company's earnings totaled -$6.77 million, or -$1.47 per share. This compares with -$6.28 million, or -$1.55 per share, last year. The company's re... Full story

Yahoo Finance • 28 days ago

UPDATE - Carlsmed® Reports Second Quarter 2025 Financial Results

Q2’25 revenue of $12.1 million, 99% YOY growth Full year revenue guidance of $45.5M - $47.5M CARLSBAD, Calif., Aug. 28, 2025 (GLOBE NEWSWIRE) -- Carlsmed, Inc. (Nasdaq: CARL) (“Carlsmed” or the “Company”), a medical technology company... Full story

Yahoo Finance • 28 days ago

Carlsmed® Reports Second Quarter 2025 Financial Results

Q2’25 revenue of $12.1 million, 99% YOY growth Full year revenue guidance of $45.5M - $47.5M CARLSBAD, Calif., Aug. 28, 2025 (GLOBE NEWSWIRE) -- Carlsmed, Inc. (Nasdaq: CARL) (“Carlsmed” or the “Company”), a medical technology company... Full story

Yahoo Finance • last month

Piper Sandler initiates Carlsmed stock with Overweight rating on custom implant potential

Investing.com - Piper Sandler initiated coverage on Carlsmed Inc (NASDAQ:CARL) with an Overweight rating and a price target of $18.00 on Monday. The company, currently valued at $360 million, has shown strong gross margins of 74% despite n... Full story

Yahoo Finance • last month

Goldman Sachs initiates coverage on Carlsmed stock with Buy rating

Investing.com - Goldman Sachs initiated coverage on Carlsmed Inc (NASDAQ:CARL) with a Buy rating and a $19.00 price target, representing approximately 40% upside potential from current levels. According to InvestingPro data, the stock’s RS... Full story

Yahoo Finance • last month

Carlsmed Inc. to Report Second Quarter 2025 Financial Results on August 28, 2025

CARLSBAD, Calif., Aug. 14, 2025 (GLOBE NEWSWIRE) -- Carlsmed, Inc. (Nasdaq: CARL), a medical technology company pioneering AI-enabled personalized spine surgery solutions, today announced it will report its second quarter 2025 financial... Full story

Yahoo Finance • 2 months ago

Carlsmed’s aprevo® Powers First Personalized Cervical Spine Surgery

CARLSBAD, Calif., July 28, 2025 (GLOBE NEWSWIRE) -- Carlsmed, Inc. (Nasdaq: CARL) (“Carlsmed”), a medical technology company pioneering AI-enabled personalized spine surgery solutions, today announced the successful completion of the fir... Full story

Yahoo Finance • 2 months ago

Carlsmed (CARL) director Sidow buys $199,995 in shares

Director Kevin Sidow of Carlsmed, Inc. (CARL:CARL) recently purchased 13,333 shares of common stock at a price of $15.00, totaling $199,995. The purchase price sits near the company’s 52-week high of $15.20, with Carlsmed currently maintai... Full story

Yahoo Finance • 2 months ago

Carlsmed director Mittendorff buys $20 million in shares

Director Robert Mittendorff reported purchasing 1,333,333 shares of Carlmed, Inc. (NASDAQ:CARL) common stock at a price of $15.0 per share, for a total transaction value of $19,999,995. The purchase price sits near the stock’s 52-week high... Full story

Yahoo Finance • 2 months ago

Carlsmed director Philip Young buys $900k in shares

Director Philip Young reported purchasing 59,999 shares of CARLSMED, INC. (NASDAQ:CARL) common stock at a price of $15.00 on July 24th, bringing the total value of the purchases to $899,985. The purchase price sits near the stock’s 52-week... Full story